© 2020 MJH Life Sciences and OncLive. All rights reserved.
April 23, 2020
David S. Snyder, MD, discusses how ruxolitinib and fedratinib may be used to pave the way toward transplant for patients with myelofibrosis.
April 08, 2020
David S. Snyder, MD, discusses tools to improve the use of allogeneic stem cell transplant in myelofibrosis.
February 26, 2020
David S. Snyder, MD, discusses updates in treating patients with myelofibrosis who undergo transplant.
February 11, 2020
David S. Snyder, MD, discusses the utility of transplant in myeloproliferative neoplasms.